Omeprazolo Hikma (Omeprazole Sodium)

Omeprazole irreversibly inhibits the H+/K+‑ATPase (gastric proton pump) on the secretory surface of parietal cells. By blocking this final step of acid secretion, it reduces gastric acidity, allowing the oesophageal and gastric mucosa to heal and relieving acid‑related symptoms.

The prescribed dose of Omeprazolo Hikma is determined by the treating physician based on the specific indication, patient age, renal function and response to therapy. Dosage regimens are individualized and should follow local prescribing guidelines.

Omeprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy or lactation only when clearly needed, after a risk‑benefit assessment by the healthcare professional.

To place an order, submit an enquiry on the Omeprazolo Hikma product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Omeprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Omeprazolo Hikma tablets should be stored at temperatures not exceeding 25 °C. Keep the product in its original blister pack, protect it from moisture and direct sunlight, and discard any tablets that appear discoloured or damaged.

The tablets are taken orally, usually before a meal—most commonly before breakfast. Swallow the tablet whole with a glass of water; do not crush, chew or split unless specifically instructed by a healthcare professional.

Serious but uncommon risks include Clostridioides difficile‑associated colitis, acute interstitial nephritis, severe allergic reactions, hypomagnesemia and increased fracture risk with prolonged use. Patients should be monitored for these events, especially during long‑term therapy.

Omeprazolo Hikma is contraindicated in individuals with known hypersensitivity to omeprazole or any excipients in the tablet. Caution is also advised for patients with severe liver impairment, and it should be avoided in those taking medications that have a contraindicated interaction, such as clopidogrel.